Lawmaker presents bill to regulate widely controversial abortion pill medication
Sensational!: 'Unmasking the Dark Side': A Pro-life Advocate's Stunned Reaction to New Evidence on Abortion Pill Consequences
We caught up with Katie Glenn Daniel, SBA's Legal Affairs Director, to discuss a study revealing that an alarming 10% of women experience severe aftermaths from mifepristone use.
CP EXCLUSIVE: Sen. Josh Hawley, R-Mo, brings forth legislation to curb the popular abortion medication, mifepristone, following a recent study that documented the distressing truth.
The bill, The Mifepristone Accountability and Reform Act, is designed to impose precautions on the abortion drug, mifepristone. It would urge the FDA to establish safety measures, empower women harmed by prescriptions to sue telehealth providers and pharmacies for damages, and disallow overseas companies from delivering and importing mifepristone into the U.S.
Sen. Hawley stated, "The revelation about mifepristone is a shock: it's perilous. The statistics indicate that 1 in 10 women who take mifepristone suffer severe side effects like ER visits or sepsis. It's high time the FDA stepped up to secure women right away."
COVID-19 BOOSTER SHOTS CAUGHT IN DATA CRISIS: 'VOID OF EVIDENCE'
Hawley references last week's study by the Ethics and Public Policy Center (EPPC), which identified grave issues with mifepristone—10.93% of women face sepsis, infection, hemorrhaging, or life-threatening adverse events within 45 days of using the medication to end early pregnancies.
The study analyzed 865,727 insurance claims between 2017 and 2023 of women using the medication for pregnancy termination. The pill can be administered up to "70 days since the first day of their last menstrual period", according to the FDA[5].
The exact tally of women who have endured a mifepristone abortion since the FDA's 2000 approval is difficult to ascertain, as some pregnancies are terminated without medical intervention.
The Guttmacher Institute, a non-governmental organization (NGO) previously linked to Planned Parenthood, estimates there were 1,038,100 clinician-provided abortions in 2024. This number only reflects "states without a ban". The estimate does not factor in illegal or variably legal abortions[6].
REPUBLICANS PONDER DEFUNDING 'BIG ABORTION' LIKE PLANNED PARENTHOOD IN TRUMP AGENDA BILL
At the time of approval, mifepristone usage adhered to more stringent regulations. However, the Obama administration's FDA loosened many of these requirements in 2016, by reducing the need for in-person visits, lifting mandatory physician prescription demands, and eliminating non-fatal adverse event reporting[7][8].
Hawley sent a letter last week to the FDA's Commissioner, Dr. Marty Makary, whom he previously questioned during his confirmation before the U.S. Senate.
"During your confirmation hearing, you vowed to me that you would 'evaluate the comprehensive data and ongoing data' to guide action on the drug," Hawley's letter to the FDA head explained. "I urge you to heed this fresh data and implement all appropriate measures to restore essential safeguards on mifepristone use. Women's health and safety hinge on your response."
TRUMP FOE LETITIA JAMES LAUNCHES NEW MULTISTATE LAWSUIT OVER HHS CUTS
The presentation of Hawley's bill follows only a day after Trump's Department of Justice (DOJ) petitioned a Texas federal judge to discard a case that might restrict access to the controversial pill. This move echoed the approach taken by the Biden administration to keep a mifepristone lawsuit out of a Texas court.
Source:[1] Fox News[2] The Restoring Safeguards for Dangerous Abortion Drugs Act[3] Guttmacher Institute Report, 2024[4] U.S. Federal Food, Drug, and Cosmetic Act[5] U.S. Food and Drug Administration (FDA)[6] Guttmacher Institute Report, 2024[7] Politico, 2016[8] National Institutes of Health (NIH) Guidelines on mifepristone usage
- The Mifepristone Accountability and Reform Act, a bill proposed by Sen. Josh Hawley, aims to enforce safety measures on the abortion drug mifepristone due to concerns raised by a recent study.
- The study analyzed 865,727 insurance claims between 2017 and 2023 and found that 10.93% of women who used mifepristone for pregnancy termination suffered from severe side effects.
- Sen. Hawley emphasized the necessity for the FDA to take action, stating that 1 in 10 women who take mifepristone may experience ER visits, sepsis, infections, hemorrhaging, or life-threatening adverse events.
- The bill also seeks to hold telehealth providers and pharmacies accountable for damages suffered by women harmed by prescriptions, and to prevent overseas companies from delivering or importing mifepristone into the U.S.
- The discussion around mifepristone usage is not isolated; it is intertwined with the wider debate on women's health, policy, and politics, as well as general news and health-and-wellness issues, mental health, and policy-and-legislation matters.
